Bionano Genomics (BNGO)
Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South...
- Open
- 1.250
- High
- 1.250
- Low
- 1.195
- Prev. Close
- 1.240
- Volume
- 177.45K
- Turnover
- 216.25K
- Avg Price
- 1.219
- Bid/Ask Ratio
- --
- Amplitude
- 4.44%
- 52wk High
- 5.500
- Volume Ratio
- 1.91
- Turnover Ratio
- 1.67%
Bionano Genomics Analyst Rating
View moreForecast & Rating
Aug 11, 2026Price forecast
$5.00316.67%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy50.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Aug 24 at 12:02 PM
Bionano to present, hold investor meetings at H.C. Wainwright Global Investment Conference
- PUBT · Aug 21 at 08:31 PM
Bionano Genomics interim CEO Albert Luderer acquires 4,000 common shares worth $4,860
- Quartr · Aug 10 at 09:31 PM
BNGO: Record Q2 revenue and margin driven by clinical adoption, with growth limited by supply constraints
- PUBT · Aug 10 at 08:12 PM
Bionano net loss widens 8.26% to $7.42 million in Q2 FY26; revenue rises 21% to $8.2 million
